Difference between revisions of "Pfizer COVID vaccine"
Jump to navigation
Jump to search
Sievert 81 (talk | contribs) |
|||
| Line 1: | Line 1: | ||
The '''Pfizer COVID vaccine''' was first approved in the [[United Kingdom]] late in 2020, for those over 16 years old. | The '''Pfizer COVID vaccine''' was first approved in the [[United Kingdom]] late in 2020, for those over 16 years old. | ||
| − | It is a novel mRNA vaccine, having data on merely 30,000 patients. The follow-up monitoring consisted of only two months. | + | It is a novel mRNA vaccine, having data on merely 30,000 patients. The follow-up monitoring consisted of only two months. It creates abnormal proteins that attack the female reproductive system. |
On Dec. 9, 2020, [[Pfizer]] issued a warning for those having allergies: | On Dec. 9, 2020, [[Pfizer]] issued a warning for those having allergies: | ||
Revision as of 05:41, December 12, 2020
The Pfizer COVID vaccine was first approved in the United Kingdom late in 2020, for those over 16 years old.
It is a novel mRNA vaccine, having data on merely 30,000 patients. The follow-up monitoring consisted of only two months. It creates abnormal proteins that attack the female reproductive system.
On Dec. 9, 2020, Pfizer issued a warning for those having allergies:
| “ | Two people who were jabbed with Pfizer’s recently-approved coronavirus vaccine in the UK had to be treated for serious adverse reactions — leading to warnings that those with “significant” allergies may not be able to get it.[1] | ” |
The meeting of the FDA advisory committee is available online, at which several dissented from recommending this vaccine to the public, particularly for those aged 16 to 18 years old.[2]